Form 8-K - Current report:
SEC Accession No. 0001493152-24-040594
Filing Date
2024-10-09
Accepted
2024-10-09 16:05:28
Documents
15
Period of Report
2024-10-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46276
2 ex3-1.htm EX-3.1 140797
3 ex4-1.htm EX-4.1 59862
  Complete submission text file 0001493152-24-040594.txt   457735

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE celc-20241007.xsd EX-101.SCH 3073
5 XBRL LABEL FILE celc-20241007_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE celc-20241007_pre.xml EX-101.PRE 24165
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3694
Mailing Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446
Business Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446 763-392-0767
Celcuity Inc. (Filer) CIK: 0001603454 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38207 | Film No.: 241362842
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)